September, 2024
Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D Financing
Read MoreMarch, 2024
Phagenesis, a medical device company specializing in the treatment of swallowing disorders, successfully closes a $42M Series D financing round led by EQT Life Sciences and Sectoral Asset Management.
Read MoreAugust, 2023
Arizona chef able to swallow again thanks to new therapy used to treat stroke patients at Banner – University Medical Center Phoenix
Read MoreMay, 2023
AU Health is the first acute care center in the U.S. to offer breakthrough dysphagia treatment
Read MoreMay, 2023